Posts

Showing posts with the label SME IPO

Multibagger debut! Shivalic Power Control shares list at 211% premium over IPO price

Image
[hfe_template id='11223'] [ad_1] The shares of Shivalic Power Control listed on the NSE SME platform with a premium of 211% on Monday. The stock debuted at Rs 311 as against an issue price of Rs 100. Ahead of the listing, the company's shares traded with a premium of Rs 175 in the unlisted market. The IPO, which was completely a fresh equity sale of 64.32 lakh shares, was subscribed over 250 times at close, driven by strong interest from retail and non-institutional investors. The net proceeds from the public offer will be used for working capital requirements, capital expenditure, inorganic growth through unidentified acquisition for company and general corporate purposes. Shivalic Power Control is an LT and HT electric panel manufacturer with an operating history of 20 years. It is a technology-driven company with a strong focus on quality, design and product development, which has allowed it to develop products suited to customers’ requirements.Also Read: IPO Cale...

Nephro Care IPO opens today: Check issue size, price band, GMP and other details

Image
[hfe_template id='11223'] [ad_1] The SME IPO of Nephro Care opened for subscription earlier today and will close on July 2. The company aims to raise about Rs 41.26 crore through the SME IPO and list the shares on NSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue. 1) About Nephro Care Nephro Care is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. 2) Industry overview CKD is a severe public health issue in India. As per government estimates, nearly 2,20,000 patients develop end-stage renal disease (ESRD) annually in India, leading to an additional annual dialysis demand of 34 million treatment sessions. Unfortunately, in India, renal insufficiency treatment focuses more on curati...